Immunomodulatory Effects of Mesenchymal Stem Cells on T- and B-Cells in a Quiescent State in a Chronic Experimental Model of Autoimmune Encephalomyelitis
Journal Title: Neuro – Open Journal - Year 2017, Vol 4, Issue 1
Abstract
Introduction: Multiple sclerosis (MS) is an immune-mediated disease affecting the central nervous system (CNS). Many drugs have been tested in animal models of MS (e.g., Experimental Autoimmune Encephalomyelitis (EAE)). Nevertheless, clinical observations indicate that suppression of the immune response is a very simple approach to address the problem, since the injuries produced by the inflammation do not predict later changes. An emerging strategy for neuroprotection and remyelination is the transplantation of stem cells. Mesenchymal stem cells (MSC) have been characterized by their multipotentiality and their capacity for immunomodulation, thus raising great expectations in regenerative medicine. Materials and Methods: In this context, we have tested the therapeutic potential of intravenously injected bone marrow-MSC from healthy rat donors in a chronic EAE model using Lewis 1A rats. We analyzed the role of MSC on T- and B-cells in the quiescent state. Results: Rat MSC expressed the vascular cell adhesion molecule CD106 to a slight extent. MSC promoted T- or B-lymphocyte survival but did not modify the T- or B-lymphocyte cell cycles in the quiescent state. Our results also confirm that MSC modulate EAE though the production of soluble cytokines. In vitro, MSC decreased the EAE by immunomodulating the Th1/Th2 response. Moreover, MSC controlled CD27/CD86 expression in different ways. Conclusion: Animals infused with MSC prior to the EAE immunization did not develop EAE, or their EAE clinical scores were decreased, whereas animals that received MSC after the induction of EAE developed a normal EAE course. This novel therapeutic strategy would further our knowledge of the pathophysiology of autoimmune diseases, which in the future could be translated into clinical application.
Authors and Affiliations
Rafael Coveñas,
Keywords
Related Articles
- EP ID EP552526
- DOI 10.17140/NOJ-4-128
- Views 135
- Downloads 0
Drugs Against Calcitonin Gene-Related Peptide and its Receptor Used in the Treatment of Migraine: What are the New Progresses?
Migraine is a chronic headache disorder that its exact pathomechanism is not very well known but research in the last two decades indicates that it might be a brain disorder, a dismodulation of sensory processing of the...
Adult Attention-Deficit and Hyperactivity Disorder and Fibromyalgia: A Case-Control Study
Introduction: Fibromyalgia syndrome (FMS) is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues. An association between attention deficit and fibromyalgia wa...
Stroke Mimics in the Pediatric Population
Pediatric stroke is a very rare condition and it is a cause of significant morbidity and mortality. It is among the top ten causes of death in the pediatric population, and over half of stroke survivors experience long-t...
Targeting Calcitonin Gene-Related Peptide and its Receptor by Monoclonal Antibody, New Developments in the Prevention of Migraine
Migraine is a chronic headache disorder with an unknown pathophysiology. Research in the past decade has shown that to be a brain disorder, a dismodulation of sensory processing affecting vascular tone and pain1-3 but si...
Neuromodulation in the Treatment of Migraine: Progress in Nerve Stimulation
Migraine is a type of primary headache disorder that can become chronic and disabling. The exact pathomechanism of migraine is not known very well and its treatment is also difficult in some cases. There are several medi...